Sumitomo Mitsui Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 308,185 shares of REGN stock, worth $175 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
308,185
Previous 303,669
1.49%
Holding current value
$175 Million
Previous $193 Million
15.99%
% of portfolio
0.1%
Previous 0.14%
Shares
33 transactions
Others Institutions Holding REGN
# of Institutions
1,420Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.36 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.81 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.22 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.75 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.18 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $61B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...